Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Leukemia, Lymphocytic, Chronic, B-Cell

abstract

  • Sequential therapy with F-->C-->R yields improvement in quality of response, with many patients achieving a PCR-negative state.

publication date

  • February 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2645858

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.16.4459

PubMed ID

  • 19075280

Additional Document Info

start page

  • 491

end page

  • 7

volume

  • 27

number

  • 4